These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4028632)

  • 1. Lack of effect of oral activated charcoal on imipramine clearance.
    Goldberg MJ; Park GD; Spector R; Fischer LJ; Feldman RD
    Clin Pharmacol Ther; 1985 Sep; 38(3):350-3. PubMed ID: 4028632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imipramine disposition in users of oral contraceptive steroids.
    Abernethy DR; Greenblatt DJ; Shader RI
    Clin Pharmacol Ther; 1984 Jun; 35(6):792-7. PubMed ID: 6734030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceleration of digoxin clearance by activated charcoal.
    Lalonde RL; Deshpande R; Hamilton PP; McLean WM; Greenway DC
    Clin Pharmacol Ther; 1985 Apr; 37(4):367-71. PubMed ID: 3978996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of size and frequency of oral doses of charcoal on theophylline clearance.
    Park GD; Radomski L; Goldberg MJ; Spector R; Johnson GF; Quee CK
    Clin Pharmacol Ther; 1983 Nov; 34(5):663-6. PubMed ID: 6627827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceleration of the body clearance of phenobarbital by oral activated charcoal.
    Berg MJ; Berlinger WG; Goldberg MJ; Spector R; Johnson GF
    N Engl J Med; 1982 Sep; 307(11):642-4. PubMed ID: 7050705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the surface area of activated charcoal on theophylline clearance.
    Park GD; Spector R; Goldberg MJ; Johnson GF; Feldman R; Quee CK
    J Clin Pharmacol; 1984 Jul; 24(7):289-92. PubMed ID: 6480875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males.
    Stass H; Kubitza D; Möller JG; Delesen H
    Br J Clin Pharmacol; 2005 May; 59(5):536-41. PubMed ID: 15842551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of sorbitol and activated charcoal on serum theophylline concentrations after slow-release theophylline.
    Goldberg MJ; Spector R; Park GD; Johnson GF; Roberts P
    Clin Pharmacol Ther; 1987 Jan; 41(1):108-11. PubMed ID: 3802699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of theophylline clearance by oral activated charcoal.
    Berlinger WG; Spector R; Goldberg MJ; Johnson GF; Quee CK; Berg MJ
    Clin Pharmacol Ther; 1983 Mar; 33(3):351-4. PubMed ID: 6337763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated clearance of intravenously administered theophylline and phenobarbital by oral doses of activated charcoal in rats. A possibility of the intestinal dialysis.
    Arimori K; Nakano M
    J Pharmacobiodyn; 1986 May; 9(5):437-41. PubMed ID: 3761133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral activated charcoal on propranolol pharmacokinetics following intravenous administration to rabbits.
    al-Meshal MA; el-Sayed YM; al-Angary AA; al-Dardiri MM
    J Clin Pharm Ther; 1993 Feb; 18(1):39-44. PubMed ID: 8473358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated oral doses of activated charcoal and the clearance of tobramycin, a non-absorbable drug.
    Watson WA; Jenkins TC; Velasquez N; Schentag JJ
    J Toxicol Clin Toxicol; 1987; 25(3):171-84. PubMed ID: 3612896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral activated charcoal and dapsone elimination.
    Neuvonen PJ; Elonen E; Mattila MJ
    Clin Pharmacol Ther; 1980 Jun; 27(6):823-7. PubMed ID: 7379451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of activated charcoal on phenytoin pharmacokinetics.
    Rowden AM; Spoor JE; Bertino JS
    Ann Emerg Med; 1990 Oct; 19(10):1144-7. PubMed ID: 2221521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imipramine-cimetidine interaction: impairment of clearance and enhanced absolute bioavailability.
    Abernethy DR; Greenblatt DJ; Shader RI
    J Pharmacol Exp Ther; 1984 Jun; 229(3):702-5. PubMed ID: 6726654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of single dose kinetics of imipramine, nortriptyline and antipyrine in man.
    Gram LF; Andreasen PB; Overo KF; Christiansen J
    Psychopharmacology (Berl); 1976 Oct; 50(1):21-7. PubMed ID: 827758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of morphine clearance following intravenous administration by oral activated charcoal in rabbits.
    el-Sayed YM; Hasan MM
    J Pharm Pharmacol; 1990 Aug; 42(8):538-41. PubMed ID: 1981579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of single and repeated doses of activated charcoal on the pharmacokinetics of doxepin.
    Scheinin M; Virtanen R; Iisalo E
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):38-42. PubMed ID: 3988390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of orally administered activated charcoal on vancomycin clearance.
    Davis RL; Roon RA; Koup JR; Smith AL
    Antimicrob Agents Chemother; 1987 May; 31(5):720-2. PubMed ID: 3606073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of imipramine and desipramine in man after different routes of administration.
    Nagy A; Johansson R
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):145-60. PubMed ID: 1102994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.